Cerebrolysin
Cerebrolysin is a peptide mixture from porcine brain tissue containing active neuropeptides. Approved in many countries for Alzheimer's disease and stroke, it has demonstrated neurotrophic and neuroprotective effects.
Protocol
5–30 mL IV infusion daily for 20-day cycles
Half-Life
Variable (peptide mixture)
Molecular Structure & Chemistry
4 residues • 49 atoms • Skeletal Formula
C14H22N4O9
318.29 g/mol
390.139 Da
2.93
-2
-1.4
Amino Acid Sequence
Biological Mechanisms
Neuroregeneration
Observed in clinical research as a primary mechanism of action for Cerebrolysin.
Alzheimer's disease treatment
Observed in clinical research as a primary mechanism of action for Cerebrolysin.
Stroke recovery
Observed in clinical research as a primary mechanism of action for Cerebrolysin.
Improved cognition and memory
Observed in clinical research as a primary mechanism of action for Cerebrolysin.
Neurotrophic factor-like effects
Observed in clinical research as a primary mechanism of action for Cerebrolysin.
Safety & Risk Analysis
Critical Safety Warning
Black market peptides can be contaminated, mislabeled, or dangerous. Only obtain peptides via a registered doctor and legitimate pharmacy. Never attempt self-administration without professional medical supervision.
Community Journey Log
Log Your Journey
Share your research observations with the community.
Sign in to contribute
Create a free account to log your research journey and share observations with the community.
Community Observations (0)
No journey logs yet. Be the first to share.
Quick Reference
This compound is for research purposes only. Clinical applications must be directed by a licensed physician.
View Community Logs